Helen Frankenthaler Foundation

Adrenorphin peptide

Adrenergic beta-2 Receptor Agonists | DrugBank

Adrenergic beta-2 Receptor Agonists

Name Adrenergic beta-2 Receptor Agonists

Accession Number DBCAT003416 (DBCAT000554, DBCAT002650)

Description Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS.

Drugs

DrugDrug Description
AbediterolAbediterol has been used in trials studying the treatment of Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Chronic Obstructive Pulmonary Disease (COPD) and Asthma.
AlbuterolA beta-2 adrenergic receptor agonist used to treat asthma, bronchitis, COPD, as well as prevent exercise induced bronchospasms.
ArbutamineUsed to elicit acute cardiovascular responses (cardiac stumulant), similar to those produced by exercise, in order to aid in diagnosing the presence or absence of coronary artery disease (CAD) in...
ArformoterolA beta-2 adrenergic agonist and bronchodilator used for long-term, symptomatic treatment of reversible bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
BambuterolA long acting beta2-adrenoceptor agonist for the management of lung diseases associated with bronchospasm.
BatefenterolBatefenterol has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.
BitolterolUsed to dilate air passages in the lungs that have become narrowed as a result of disease or inflammation. It is used in the treatment of asthma and chronic obstructive...
CeliprololA beta-blocker for the management of hypertension and angina pectoris.
ClenbuterolA decongestant and bronchodilator used in a variety of respiratory conditions.
DipivefrinA prodrug of epinephrine used in ophthalmic solutions to reduce intraocular pressure in chronic open-angle glaucoma.
DobutamineA beta-1 agonist used to treat cardiac decompensation in patients with organic heart disease or from cardiac surgery.
DoxofyllineA methylxanthine derivative used in chronic obstructive pulmonary disease, asthma, and bronchospasms.
DroxidopaA medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease.
Ephedra sinica rootAn alpha and beta-adrenergic agonist used for the management of respiratory conditions related to bronchial asthma, such as wheezing, shortness of breath, and tightness of chest.
EpinephrineA hormone and neurotransmitter used to treat allergic reactions, to restore cardiac rhythm, and to control mucosal congestion, glaucoma, and asthma.
EtafedrineA beta-2 adrenoceptor agonist used to treat a cough associated with inflamed mucosa.
FenoterolA beta-2 adrenergic agonist and bronchodilator used for the symptomatic treatment of asthma.
FormoterolAn inhaled long-acting beta2-adrenergic receptor agonist used as a bronchodilator in the management of asthma and COPD.
HexoprenalineHexoprenaline is a stimulant of beta 2 adrenergic receptors. It is used as a bronchodilator, antiasthmatic, and tocolytic agent.
IndacaterolAn inhaled long-acting beta-2 adrenergic agonist used to relax bronchial smooth muscle and improve symptoms and airflow obstruction caused by Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma.
IsoetharineFor the treatment of asthma, wheezing, and chronic asthmatic bronchitis.
IsoprenalineA catecholamine non-selective beta-adrenergic agonist typically used to treat bradycardia and heart block.
LevosalbutamolA beta-2 adrenergic receptor agonist used to treat COPD and asthma.
NorepinephrineA sympathomimetic used in the control of blood pressure during various hypotensive states and as an adjunct treatment during cardiac arrest.
OlodaterolA long-acting beta2-adrenergic agonist used in the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
OrciprenalineA beta-2 adrenergic agonist used to treat bronchospasm, asthma, and COPD.
PF-00610355PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others.
PhenylpropanolamineA sympathomimetic that was previously used in nasal decongestants and weight loss products, but has been withdrawn by the FDA due to safety risks and lack of efficacy.
PirbuterolA beta-2 adrenergic agonist and bronchodilator used for the symptomatic treatment of asthma.
ProcaterolA beta-2 adrenergic receptor agonist and bronchodilator used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
ProtokylolProtokylol is a β-adrenergic receptor agonist used as a bronchodilator in Europe and the United States.
RacepinephrineA bronchodilator used to treat intermittent asthma.
RitodrineAn adrenergic beta agonist used to treat premature labor.
SalmeterolA long-acting beta-2 adrenergic receptor agonist used to treat asthma and COPD.
TerbutalineA beta-2 adrenergic agonist used as a bronchodilator and to prevent premature labor.
VilanterolA long-acting beta2-adrenergic agonist used in combination with other bronchodilators for the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Drugs & Drug Targets

DrugTargetType
AbediterolBeta-2 adrenergic receptortarget
AlbuterolBeta-3 adrenergic receptortarget